Pneumovax Related Clinical Trials
Systems Biology of PNEUMOVAX�23 and PREVNAR 13� [Active, not recruiting]
The Effect of Short-term Atorvastatin Treatment on Immune Responses to Pneumovax 23 [Completed]
A Study to Compare the Safety and Immunogenicity of Pneumococcal Conjugate Vaccines in Healthy Volunteers (V114-002) [Completed]
Immunogenicity of Pneumococcal Vaccines in Ataxia-telangiectasia Patients [Not yet recruiting]
Safety and Immunogenicity of a 10 Valent Pneumococcal Conjugate Vaccine (SIILPCV10) in Healthy Adults, Toddlers, Infants [Recruiting]
Immunogenicity of Repeated Dose 13-valent Pneumococcal Conjugate Vaccine Compared to the Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients [Recruiting]
Comparing Two Pneumococcal Vaccines in Adults With Chronic Obstructive Pulmonary Disease [Completed]
Effect of Obesity on Immune Response to Pneumovax 23 [Not yet recruiting]
Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients [Completed]
Pneumococcal Vaccine in Untreated CLL Patients [Recruiting]
Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan) [Completed]
Pneumococcal Conjugate Vaccine Followup [Completed]
Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines [Completed]
PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae [Completed]
Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines [Completed]
Polysaccharide Antibody Response Study [Not yet recruiting]
Pneumococcal Adult-dose Ranging Immunization Study [Completed]
Safety, Tolerability and Immunogenicity of Pneumovax 23 in Healthy Adults in India (V110-011) [Completed]
A Study To Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal Bacteria [Completed]
Safety and Immunogenicity of a Newly 23-valent Pneumococcal Polysaccharide Vaccine in Chinese Adults and Children [Completed]
Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®) [Completed]
Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses [Recruiting]
13 Valent Pneumococcal Conjugate Vaccine - Follow-on Study [Completed]
Effects of Different Anti-rheumatic Treatments of Arthritis on Antibody Response Following Pneumococcal Vaccination Using Prevenar® [Enrolling by invitation]
Study Assessing the Effect of Medications to Prevent Fever on Prevenar 13® [Completed]
PPSV23 Pneumococcal Vaccine in Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Effectiveness of the Pneumococcal Polysaccharide Vaccine in Military Recruits [Completed]
Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007) [Completed]
Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children. [Completed]
Study of Two Investigational Pneumococcal Vaccines in Healthy Adults [Completed]
Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected Adults [Recruiting]
Vaccination Course in Primed Children and Age-matched Unprimed Children With Pneumococcal Vaccine GSK1024850A [Completed]
Study Response of 13-valent Conjugate Pneumococcal Vaccine in Patients With End Stage Renal Disease [Recruiting]
Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants. [Completed]
Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children [Recruiting]
Impact and Cost of a Pharmacist Pneumococcal Vaccination Program With PNEUMOVAX® 23 at an Urban Senior Center [Active, not recruiting]
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in Brazil [Completed]
Study of an Investigational Pneumococcal Vaccine in Healthy Adult Volunteers [Completed]
Protection Against Pneumococcal Infection in Children With T1DM [Recruiting]
Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine [Completed]
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine [Completed]
Evaluation of Pneumococcal Vaccine Formulations in Young Adults [Completed]
Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants [Completed]
PCV13 + Hepatitis A Vaccine for Adults [Not yet recruiting]
Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines. [Completed]
Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD [Recruiting]
Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response [Not yet recruiting]
Study to Compare Pediacel� to Infanrix�-IPV+Hib When Both Are Co-Administered With Prevenar� in Infants and Toddlers [Completed]
Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Mali [Completed]
13vPnC Multidose Vial Safety, Tolerability and Immunogenicity Study in Healthy Infants. [Completed]
Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of Life [Enrolling by invitation]
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age [Completed]
Analysis of the Mechanisms of Protective Humoral Immunity in Response to the Pneumococcal Vaccine [Completed]
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants [Completed]
Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants [Completed]
Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, Vietnam [Recruiting]
Safety and Immunogenicity of 23-valent Pneumococcal Polysaccharide Vaccine in 2 to 70 Years Old Healthy People in China [Completed]
Effect of Two Versus Three Pneumococcal Conjugate Vaccinations [Completed]
Study Evaluating Prevnar Infant Long-term Immune Response Versus Prevnar Naive Cohort [Completed]
V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019) [Completed]
Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque Psoriasis [Completed]
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age [Completed]
Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A [Completed]
Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants [Completed]
Pneumococcal Reference Standard [Completed]
Targeting of Immune Response After Pneumococcal Vaccination [Completed]
Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines [Active, not recruiting]
Study Evaluating Antibody Response Of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) 24 Months After Toddler Dose. [Completed]
Immunogenicity and Safety of a Booster Dose of Pneumo 23® in 12 to 18 Months-Old Children Primed With Prevnar [Completed]
Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults [Completed]
A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants [Not yet recruiting]
Pneumococcal Vaccines Early and in Combination [Recruiting]
Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults. [Completed]
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age [Completed]
Prevenar13 Post Market Surveillance [Active, not recruiting]
A Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Japanese Elderly Adults Aged 65 Years Old and Older [Completed]
Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants [Completed]
Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants. [Completed]
Study Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization [Completed]
Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age. [Completed]
Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A [Completed]
|